HSK31858

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Efficacy and SafetyAsthmaAdultTicsCystic Fibrosis

242 competitors in Efficacy and Safety

#DrugCompanyPhaseTrials

1

HSK31858

Haisco Pharmaceutical Group Co., Ltd.

Phase 3

12

VAY736

Novartis

Phase 3

23

TLL-018

HHangzhou Highlightll Pharmaceutical Co., Ltd

Phase 3

14

VDPHL01

VVeradermics, Inc.

Phase 3

15

KN057

SSuzhou Alphamab Co., Ltd.

Phase 3

26

IBI302

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3

17

AD-209

AAddpharma Inc.

Phase 3

28

QL1206

Qilu Pharmaceutical Co., Ltd.

Phase 3

29

ZM-H1505R

SShanghai Zhimeng Biopharma, Inc.

Phase 3

210

Tribulus Terrestris

FFederal University of Minas Gerais

Phase 3

1Show 31 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Cystic Fibrosis2 trials

A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Recruiting·Haisco Pharmaceutical Group Co., Ltd.·Phase 3·NCT06660992·669 enrolled

A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis

Completed·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT05601778·226 enrolled

PK/PD1 trial

Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers

Completed·Haisco Pharmaceutical Group Co., Ltd.·Phase 1·NCT05663593·74 enrolled

Single Ascending Dose1 trial

A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers

Completed·Haisco Pharmaceutical Group Co., Ltd.·Phase 1·NCT05023525·32 enrolled

Adult1 trial

Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.

Active, not recruiting·XXizang Haisco Pharmaceutical Co., Ltd·Phase 1·NCT06569784·6 enrolled

Tics1 trial

Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects

Enrolling by invitation·Haisco Pharmaceutical Group Co., Ltd.·Phase 1·NCT07134465·24 enrolled

2 more indications

Asthma1 trial

A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma

Enrolling by invitation·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT06637254·219 enrolled

Efficacy and Safety1 trial

A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion

Enrolling by invitation·Haisco Pharmaceutical Group Co., Ltd.·Phase 2·NCT06820749·309 enrolled

Details

Drug Info

Related News